Core Viewpoint - The event highlighted the innovative application of AI in chronic disease management by Ark Cloud Health, showcasing its leadership in the digital healthcare sector and its recognition as a top case in 2025 by Central Radio and Television Financial. Group 1: AI and Chronic Disease Management - Ark Cloud Health has developed an innovative H2H (Hospital to Home) smart medical ecosystem to address inefficiencies in traditional chronic disease management, completing an "AI+H2H" technology upgrade this year [2]. - The company has created multiple AI core application products based on its self-developed large model, providing comprehensive service coverage for patients, doctors, and industry partners [2]. - The AI medication assistant offers medication reminders and prescription consultations, while the AI doctor assistant provides 24/7 intelligent pre-consultation and case organization, significantly enhancing doctors' diagnostic efficiency [2]. Group 2: Business and Social Value - The "AI+Chronic Disease Management" approach emphasizes measurable and replicable business and social value, with a "familiar doctor-patient" service model that fosters long-term management and high user retention, evidenced by an 85.4% repurchase rate among paid users [3]. - Ark Cloud Health collaborates with industry partners, including Tencent Health, to promote high-quality development in internet healthcare, marking a new phase in chronic disease management [3]. - Strategic partnerships with leading biopharmaceutical companies aim to create a comprehensive service system for chronic disease management, injecting new momentum into the industry's intelligent, compliant, and efficient development [3]. Group 3: Policy and Future Outlook - The global economic landscape is shifting, with AI emerging as a key driver for industrial upgrades, supported by favorable policies for AI applications in healthcare [4]. - Ark Cloud Health's unique "AI+Chronic Disease Management" path reflects its deep integration of technological innovation and industry application, receiving recognition as a top case for its contributions to public health [4]. - The company plans to deepen its large model capabilities and expand application scenarios in chronic disease management, focusing on real patient needs and contributing to global solutions in chronic disease management [4].
拓展“AI+慢病管理”应用场景,方舟云康获评央广财经“金顶”优秀案例
Jiang Nan Shi Bao·2025-12-18 08:15